News Release

RNA interference plays bigger role than previously thought

IBM and Genome Institute of Singapore report in Nature

Peer-Reviewed Publication

Agency for Science, Technology and Research (A*STAR), Singapore

ARMONK, NY, and SINGAPORE – In a paper published today online in the journal Nature, IBM (NYSE: IBM) and the Genome Institute of Singapore (GIS) reported findings from a joint research study that provides new information on how stem cell differentiation is controlled by microRNAs.

The two teams have shown that microRNAs -- small molecules that are an important regulatory component in the machinery of living cells -- have roles that go well beyond what was previously thought.

In 2006, IBM scientists developed a mathematical model that led to a conjecture about an expanded role for microRNAs. The team decided to test the hypothesis by focusing on mouse stem cells. IBM used computation to guide the experimental effort that GIS carried out.

The work is expected to provide new insights on stem cell differentiation as well as on the role of microRNAs in cell process regulation and the onset of cancer, neurodegenerative disorders, diabetes and other diseases. The research is also expected to suggest future avenues for novel diagnostics and the development of therapeutics.

"We have made yet another step towards understanding the intricate nature of microRNAs and the roles they play in the regulation of cellular processes," said Isidore Rigoutsos, manager of the Bioinformatics Group in IBM Research's Computational Biology Center. "The finding that microRNAs can extensively target locations in the amino acid coding regions of a transcript is an exciting discovery and reveals another important aspect of microRNA activity."

GIS Senior Group Leader Bing Lim added, "We learn from this study that the targeting of coding regions by microRNAs can also have a real impact on cells. We observed that a single microRNA forced into the powerful embryonic stem cell can impose differentiation. This is exciting because one could envisage using microRNAs as a small molecule to control the differentiation of stem cells, or to make new stem cells. The fun part of this research was the visualization of a trend of thought from computational prediction all the way to cell transformation."

Details of discovery:

For more than a decade, microRNAs were assumed to interact primarily with their targets through the 3' untranslated region (3'UTR) of the targets' mRNA. The nucleotide sequences of the targeted locations were believed to be generally conserved across different organisms whereas interactions with mRNA regions beyond the 3'UTR were thought to be atypical.

Some of the new research findings suggest that microRNA targets in the amino acid coding region (CDS) of a gene's mRNA may in fact be as frequent as those in the mRNA's 3'UTR, providing experimental evidence to a conjecture put forth in an earlier publication by the two teams. It also shows that a gene's CDS serves as template of microRNA targeting activity, in addition to its coding for the corresponding protein's amino acid sequence.

Working with three microRNAs whose expression increases upon differentiation of mouse embryonic stem cells (ESCs), the teams showed that Nanog, Oct4 and Sox2, three transcription factors that are central to maintaining the pluripotency of mouse ESCs and determining the initiation of differentiation, are controlled through their CDS region by the three studied microRNAs. By introducing mutations at the identified target locations, the two teams showed that they could prevent the down-regulation of these transcription factors and delay stem cell differentiation.

For the majority of the validated microRNA targets, their sequence is not conserved in the rhesus monkey and mouse counterparts of Nanog, Oct4 and Sox2. This suggests that seeking putative microRNA targets by aligning the instances of a gene across different organisms will underestimate the number of bona fide microRNA targets.

Additionally, the studied microRNAs generally have multiple targets in the CDS region of the same gene possibly suggesting an underlying need for redundancy that can ensure the downregulation of the intended target.

Finally, several of the studied targets stride exon-exon junctions: this finding suggests that microRNAs play a role in the selective targeting of a gene's splice variants.

"This discovery has vast implications for the role that computational models can play in biological science," said Ajay Royyuru, senior manager for the Computational Biology Center at IBM Research. "Computational biology allows scientists to develop theories using powerful computers and even preliminarily prove those theories prior to conducting experiments in wet labs – which reduces the time spent on trial and error throughout the process of scientific discovery."

GIS Executive Director Edison Liu said, "This work is a great example of how future medical discovery will progressively require the joint efforts of computer scientists working in conjunction with biologists. The complexity of the control of human cells through regulatory networks demands computational modeling in order to decipher the signals from the noise. But in the end, it still boils down to doing the lab experiment."

###

The report on this work, "MiRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation," by I. Rigoutsos of IBM T.J. Watson Research Center, Yorktown Heights, NY, and, Y. Tay, J. Zhang, A. Thomson, and B. Lim of the Genome Institute of Singapore, is published online in the Sept. 2008 issue of the journal Nature.

Authors: Yvonne Tay, 1 Jinqiu Zhang, 1 Andrew M. Thomson, 1,4 Bing Lim1,2,4 & Isidore Rigoutsos3,4

1. Stem Cell and Developmental Biology, Genome Institute of Singapore, Agency for Science Technology and Research, Genome, 60 Biopolis Street, Singapore 138672, Singapore.
2. Beth-Israel Medical Center, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, Massachusetts 02215, USA.
3. Bioinformatics and Pattern Discovery Group, IBM Thomas J. Watson Research Center, Yorktown Heights, PO Box 218, New York 10598, USA.
4. Co-senior authors

IBM Research:

IBM Research is the world's largest information technology research organization, with about 3,000 scientists and engineers globally. For more information, visit http://www.research.ibm.com.

Genome Institute of Singapore (GIS):

GIS, a member of the Agency for Science, Technology and Research (A*STAR), is a national initiative with a global vision that seeks to use genomic sciences to improve public health and public prosperity. Established in 2001 as a centre for genomic discovery, the GIS pursues the integration of technology, genetics and biology towards the goal of individualized medicine. Key research areas include systems biology, stem cell & developmental biology, cancer biology & pharmacology, human genetics, infectious diseases, genomic technologies, and computational & mathematical biology. GIS' genomics infrastructure is utilized to train new scientific talent, function as a bridge for academic and industrial research and explore scientific questions of high impact. For more information, please visit www.gis.a-star.edu.sg

For enquiries, please contact:

Genome Institute of Singapore
Winnie Serah Lim
Office of Corporate Communications
Tel: (65) 6478 8013
(65) 9730 7884
Email: limcp2@gis.a-star.edu.sg

IBM Media Relations:
Jenny Galitz McTighe
Tel: 914-945-1016
Email: galitz@us.ibm.com


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.